benzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral Gel

RxCUI
1006079
RxNorm name
benzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral Gel
Display name
Benzocaine/Menthol (Oral Gel)
Full name
benzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral Gel
Term type
SCD
Status
Active
Strength
20-2%
Dose form
Gel
Route
Oral Gel
Updated
2026-06-05 07:03:37

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092010
Active start
092010
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
benzocaine0.2 MG / 1 MGbenzocainebenzocaine
menthol0.02 MG / 1 MGmentholmenthol

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Gel346169

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzocaine1399
menthol6750

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRbenzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral GelNAMES
RxNorm Namebenzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral GelNAMES
RxNorm Synonymbenzocaine 20 % / menthol 2 % Mucous Membrane Topical GelNAMES
TTYSCDATTRIBUTES
SPL_SET_ID078fcdab-38a1-4a9a-bdd3-e17446591ea8CODES
RxCUI1006079CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
10157-2127-110157-2127Kanka Triple Action BENZOCAINE and MENTHOL, UNSPECIFIED FORMBlistex Inc.M022

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M02210157-2127Kanka Triple Action BENZOCAINE and MENTHOL, UNSPECIFIED FORMOTC MONOGRAPH DRUGBlistex Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11SourceActive
10157212701rxnav_ndcsyes
10310037770rxnav_historical_indirect

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Kanka Triple ActionBENZOCAINE AND MENTHOL, UNSPECIFIED FORMBlistex Inc.078fcdab-38a1-4a9a-bdd3-e17446591ea82025-01-09WarningsExact identifier
ndc (package): 10157-2127-1
ndc (product): 10157-2127
ndc11 (package): 10157212701
rxcui: 1006079

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
078fcdab-38a1-4a9a-bdd3-e17446591ea8benzocaine 20 % / menthol 2 % Mucous Membrane Topical GelSY1Kanka ® Triple Action Gel20250109
078fcdab-38a1-4a9a-bdd3-e17446591ea8benzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral GelSCD1Kanka ® Triple Action Gel20250109
078fcdab-38a1-4a9a-bdd3-e17446591ea8benzocaine 20 % / menthol 2 % Oral GelPSN1Kanka ® Triple Action Gel20250109

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
078fcdab-38a1-4a9a-bdd3-e17446591ea8Kanka ® Triple Action GelBlistex Inc.20250109

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4benzocaine
ATCR02ADAnesthetics, localATC1-4benzocaine
ATCN01BAEsters of aminobenzoic acidATC1-4benzocaine
ATCC05ADLocal anestheticsATC1-4benzocaine
FDASPLN0000185508Standardized Chemical AllergenEPChas_epcbenzocaine
FDASPLN0000184306Cell-mediated ImmunityPEhas_pebenzocaine
FDASPLN0000175629Increased Histamine ReleasePEhas_pebenzocaine
MEDRTD001566BenzocaineCHEMhas_ingredientbenzocaine
MEDRTD008610MentholCHEMhas_ingredientmenthol
MEDRTD001424Bacterial InfectionsDISEASEci_withbenzocaine
MEDRTD002056BurnsDISEASEmay_treatbenzocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withmenthol
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzocaine
MEDRTD004433EaracheDISEASEmay_treatbenzocaine
MEDRTD005401Fissure in AnoDISEASEmay_treatbenzocaine
MEDRTD006484HemorrhoidsDISEASEmay_treatbenzocaine
MEDRTD006561Herpes SimplexDISEASEmay_treatbenzocaine
MEDRTD019226Oral UlcerDISEASEmay_treatbenzocaine
MEDRTD010032Otitis ExternaDISEASEmay_treatbenzocaine
MEDRTD010033Otitis MediaDISEASEmay_treatbenzocaine
MEDRTD010146PainDISEASEmay_preventbenzocaine
MEDRTD010146PainDISEASEmay_treatmenthol
MEDRTD011537PruritusDISEASEmay_treatbenzocaine
MEDRTD012871Skin DiseasesDISEASEmay_treatmenthol
MEDRTD014098ToothacheDISEASEmay_treatbenzocaine
MEDRTN0000000069Calcium Channel AntagonistsMOAhas_moamenthol
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabenzocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pebenzocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pementhol

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.2 MG/MG / 0.02 MG/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSCD
CODESRxCUI1006079
CODESSPL_SET_ID078fcdab-38a1-4a9a-bdd3-e17446591ea8
NAMESPrescribable Synonymbenzocaine 20 % / menthol 2 % Oral Gel
NAMESRXNAV_STRbenzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral Gel
NAMESRxNorm Namebenzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral Gel
NAMESRxNorm Synonymbenzocaine 20 % / menthol 2 % Mucous Membrane Topical Gel
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels